Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1639500 | PMC |
http://dx.doi.org/10.1136/bmj.1.6013.837-e | DOI Listing |
Clin Exp Dermatol
December 2022
Department of Dermatology, University of California, Davis, Sacramento, CA, USA.
CDKN2A at chromosome positon 9p21 is a tumour suppressor gene encoding the cell cycle regulators p16 and p14ARF. While melanoma is associated with variants affecting both transcripts, families with mutations involving the p14ARF-specific exon 1B may be predisposed to central nervous system tumours. We describe a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumours and various malignancies.
View Article and Find Full Text PDFPresse Med
June 2011
Centre hospitalier de Valence, service de médecine interne, 26953 Valence cedex 9, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!